GlassScriptPhysician profile
Haley J Murphy
NPI 1891279030
$4,722.42
in general payments reported to CMS, 2019-2025
25 companies · $2,442 in 2025
The $2,442 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $252 · 2023: $345 · 2024: $1,474 · 2025: $2,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,194 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,193.75 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,034.00 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $715.06 | 2024-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Viatris Specialty LLC | $361.26 | 2025 | Yupelri |
| Genzyme Corporation | $341.25 | 2024-2025 | |
| Inspire Medical Systems, INC. | $281.16 | 2024-2025 | Inspire |
| Novo Nordisk INC | $271.99 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Mylan Specialty L.P. | $269.66 | 2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $230.36 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $178.49 | 2023-2025 | Ofev, Jascayd |
| Grifols USA, LLC | $157.88 | 2025 | Prolastin-C Liquid |
| Insmed, INC. | $144.69 | 2024-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $109.06 | 2024-2025 | Dupixent |
| Electromed, INC. | $105.14 | 2024-2025 | Smartvest |
| Harmony Biosciences LLC | $104.89 | 2024-2025 | |
| Lilly USA, LLC | $82.81 | 2021-2023 | Mounjaro |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $66.57 | 2022-2023 | |
| Philips North America LLC | $54.48 | 2025 | Vest Therapy Und |
| Fisher & Paykel Healthcare INC | $47.35 | 2025 | Fisher & Paykel Healthcare |
| Axsome Therapeutics, INC. | $44.19 | 2025 | Sunosi |
| Abbvie INC. | $36.09 | 2022-2023 | |
| Tactile Systems Technology INC | $26.11 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.13 | 2024 | Glassia |
| Ani Pharmaceuticals, INC. | $17.56 | 2024 | Purified Cortrophin Gel |
| Baxter Healthcare | $15.75 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Genentech USA, INC. | $2.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.